Skip to main content
. Author manuscript; available in PMC: 2018 Apr 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2017 Apr;69(4):599–604. doi: 10.1002/acr.22972

Table 2.

Comparisons of SLE patients with established ACR/SLICC criteria who had SLE vs. non-SLE primary causes of ESRD in the USRDS at the Montefiore Medical Center*

ACR/SLICC+ SLE classified as SLE in the USRDS
N=77
ACR/SLICC+ SLE classified as non-SLE in the USRDS
N=20
p value**

Age at ESRD onset, mean (SD), years 37 (13) 45 (16) 0.11

Sex, n(%) men 10 (13) - 0.30

Black race, n(%) 41 (54) 15 (79) 0.048

Hispanic ethnicity, n(%) 44 (58) - 0.01

Hemodialysis as the initial renal replacement modality 68 (88) 20 (100) 0.11

Transplant recipients, n (%) 40 (52) - 0.01

Year of ESRD recorded
<2004 24 (31) -
2004–2009 40 (52) -
>2009 13 (17) - 0.11
*

In accordance with the Centers for Medicare and Medicaid Services release of data requirements, cells with fewer than 10 patients per cell were suppressed

**

p-value for Wilcoxon-Mann-Whitney tests for continuous variables, and Pearson’s Chi-square tests or Fisher’s exact tests for categorical variables